Day: September 16, 2025

CINCINNATI, Sept. 16, 2025 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, will host a PECO GROW Update for financial advisors and retail investors on Wednesday, September 24, 2025, at 12:00 p.m. ET. During the webcast, PECO will discuss the business and answer questions from financial advisors and retail investors. Chairman and Chief Executive Officer Jeff Edison, President Bob Myers and Chief Financial Officer John Caulfield will host the webcast and Q&A session. The PECO GROW presentation will be posted on the Investor Relations section of the Company’s website at Investor Relations | Phillips Edison. PECO GROW Webcast Details: Date: Wednesday, September 24,...

New Study Strengthens Rationale for Spectral’s PMX Therapy by Defining Endotoxic Septic Shock (ESS) as the Highest-Risk Patient Group TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today highlighted newly published findings in Critical Care Explorations that define endotoxic septic shock (“ESS”) as a distinct and deadly form of septic shock. The prospective, multicenter observational study of 90 patients demonstrated that those with ESS – defined as endotoxin activity assay (“EAA™”) ≥ 0.6 combined with a Multiple Organ Dysfunction Score (“MODS”) > 9 or a Sequential Organ Failure Assessment (“SOFA”) > 11 – had a 28-day mortality rate of 57.1%, compared with only 15.9% in other...

DALLAS, Sept. 16, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that, by letter dated September 9, 2025, the Company was notified by The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) had granted the Company’s request for continued listing on Nasdaq, subject to the Company (i) evidencing compliance with Nasdaq’s periodic reporting requirement by filing its Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (together, the “Delayed Reports”), with the Securities...

MALVERN, Pa., Sept. 16, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced the publication of a new article in a peer-reviewed journal Biomolecules, which describes the pharmacokinetic (PK) profile of a new crystal form of buntanetap and compares it to the old form across several studies including mice, dogs, and humans. The original anhydrous form of buntanetap has been used in all preclinical and clinical studies to date. Recently, the Annovis team identified a new dihydrate crystal, which incorporates two moles of water in its structure and offers greater stability. This publication examines how...

VANCOUVER, British Columbia, Sept. 16, 2025 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or “the Company”; TSXV: AMM; OTCQB: AAUAF) provides an update to the international arbitration proceedings (the “Claim”) under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) with the United Mexican States (“Mexico”). Almaden is pursuing the Claim together with Almadex Minerals Ltd. (“Almadex”), on behalf of themselves and their Mexican subsidiaries (the “Claimants”). Prior to the illegal acts of Mexico which resulted in the complete loss of the investment, Almaden held 100% of the Ixtaca precious metals project in Mexico (the “Project”), while Almadex held a 2.0% NSR royalty on the Project. Further to the Company’s press release of July 28, 2025 which reported on the three-person arbitration panel’s...

Document is accessible on SEDAR+ and EDGAR DENVER, Sept. 16, 2025 (GLOBE NEWSWIRE) — Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, announced today that it has filed a final short-form base shelf prospectus (the “Prospectus”) with the securities commissions in each of the provinces of Canada, other than Quebec. A corresponding registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Commission (the “SEC”) under the United States Securities Act of 1933, as amended, and has become effective under the U.S./Canada Multijurisdictional Disclosure System. The filing of the Prospectus and Registration Statement will allow Intermap...

LISBON, Portugal, Sept. 16, 2025 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCID: HYOR), a US-listed leader in modular green fuel technologies, has signed a definitive joint venture agreement with Portuguese waste infrastructure and fuels company Start Lda to co-develop and operate a national network of green methanol plants using HyOrc’s proprietary RDF-to-methanol technology. The JV will deploy an initial 35 Tons Per Day (TPD) launch unit in Porto, producing 8 TPD of methanol, before scaling to five full-scale sites, each processing 300 TPD of Municipal Waste in the form of Refuse-Derived Fuel (RDF) to produce 80 TPD of green methanol. The project supports Europe’s transition away from fossil fuels and aligns with decarbonization goals in shipping and heavy industry. Projected 10-Year Revenue Exceeds $3 BillionOver a 10-year period,...